Market Cap (In CNY)
3.27 Billion
Revenue (In CNY)
1.18 Billion
Net Income (In CNY)
73.66 Million
Avg. Volume
2.34 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.74-14.4
- PE
- -
- EPS
- -
- Beta Value
- 0.455
- ISIN
- CNE1000032V9
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jian Fei Qin
- Employee Count
- -
- Website
- https://www.medisan.com.cn
- Ipo Date
- 2017-09-25
- Details
- Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical pharmaceutical dosage forms and APIs in China. It offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, body fluid balance infusion, and other medical fields. The company was founded in 1996 and is based in Harbin, China.
More Stocks
-
HAGHensoldt AG
HAG
-
STI
-
BZYR
-
ZEEL
-
5009
-
1860Mobvista Inc.
1860
-
TISCYTaisei Corporation
TISCY
-
BSM